Aimei Health Technology Co. Ltd. has announced the extension of its financial arrangement, enabling the company to further its business combination efforts. On July 6, 2025, Aimei Health Technology deposited an aggregate of $150,000 into its trust account, facilitating a one-month extension of its initial business combination period from July 6, 2025, to August 6, 2025. This extension is part of up to 12 extensions allowed under the company's Amended and Restated Articles of Association. Concurrently, Aimei Health issued an unsecured promissory note totaling $150,000 to its sponsor, Aimei Health Ltd., and United Hydrogen Group Inc., with each contributing $75,000. This note, which does not bear interest, is set to mature upon the company's consummation of a business combination with United Hydrogen. The involved parties retain the option to convert this note into private units of Aimei Health, consisting of ordinary shares and rights to additional shares, prior to the business combination's closing.